Effect of polyamine homologation on the transport and biological properties of heterocyclic amidines

Journal of Medicinal Chemistry

Volumn 49, Issue 1, 2006, Pages 232-245

  Delcros, Jean Guy ^a   Tomasi, Sophie ^a   Duhieu, Stéphane ^a   Foucault, Marine ^a   Martin, Bénédicte ^a   Le Roch, Myriam ^a   Eifler Lima, Vera ^a,b   Renault, Jacques ^a   Uriac, Philippe ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROQUINOLINE DERIVATIVE; EFLORNITHINE; HETEROCYCLIC AMINE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL TRANSPORT; CHO CELL; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TRANSPORT; LEUKEMIA L 1210; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMIDINES; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BIOLOGICAL TRANSPORT; CALMODULIN; CELL LINE, TUMOR; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CYCLIZATION; DRUG SCREENING ASSAYS, ANTITUMOR; EFLORNITHINE; GUANIDINES; MICE; MOLECULAR STRUCTURE; POLYAMINES; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 30544437848     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050018q     Document Type: Article

References (98)

1. Marton, L. J.; Pegg, A. E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 55-91.
2. Pegg, A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 1988, 48, 759-774.
3. Seiler, N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr. Drug Targets 2003, 4, 537-564.
4. Seiler, N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr. Drug Targets 2003, 4, 565-585.
5. Karigiannis, G.; Papaioannou, D. Structure, biological activity and synthesis of polyamine analogues and conjugates. Eur. J. Org. Chem. 2000, 1841-1863.
6. Marton, L. J.; Feuerstein, B. G. Polyamine-DNA Interactions: Possible site of new cancer chemotherapeutic intervention. Pharm. Res. 1986, 3, 311-317.
7. Seiler, N.; Dezeure, F. Polyamine transport in mammalian cells. Int. J. Biochem. 1990, 22, 211-218.
8. Seiler, N.; Delcros, J. G.; Moulinoux, J. P. Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell Biol. 1996, 28, 843-861.
9. Chao, J.; Seiler, N.; Renault, J.; Kashiwagi, K.; Masuko, T.; Igarashi, K.; Williams, K. N-1-dansyl-spermine and N-1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: Block and permeation of N-methyl-D-aspartate receptors. Mol. Pharmacol. 1997, 51, 861-871.
10. Holley, J. L.; Mather, A.; Wheelhouse, R. T.; Cullis, P. M.; Hartley, J. A.; Bingham, J. P.; Cohen, G. M. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res. 1992, 52, 4190-4195.
11. Rodger, A.; Blagbrough, I. S.; Adlam, G.; Carpenter, M. L. DNA binding of a spermine derivative: Spectroscopic study of anthracene-9-carbonyl-N-1- spermine with poly[d(G-C)·(d(G-C)] and poly[d(A-T)·d(A-T)]. Biopolymers 1994, 34, 1583-1593.
12. Clark, A. S.; Deans, B.; Stevens, M. F.; Tisdale, M. J.; Wheelhouse, R. T.; Denny, B. J.; Hartley, J. A. Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug Temozolomide. J. Med. Chem. 1995, 38, 1493-1504.
13. Flanagan, M. E.; Rollins, S. B.; Williams, R. M. Netropsin and spermine conjugates of a water-soluble quinocarcin analog: Analysis of sequence-specific DNA interactions. Chem. Biol. 1995, 2, 147-156.
14. Symons, M. C. Polyamines to target drugs to DNA. Free Radical Res. 1995, 22, 1-9.
15. Sessler, J. L.; Andrievsky, A.; Sansom, P. I.; Kral, V.; Iverson, B. L. Enhanced DNA photocleavage and binding properties of saphyrin-polyamine conjugates. Bioorg. Med. Chem. Lett. 1997, 7, 1433-1436.
16. 1-(acridin-9- ylcarbonyl)spermine at homopurine sites of duplex DNA. Chem. Commun. 1998, 929-930.
17. Pitie, M.; Meunier, B. Preparation of a spermine conjugate of the bis-phenanthroline ligand Clip-Phen and evaluation of the corresponding copper complex. Bioconjugate Chem. 1998, 9, 604-611.
18. Phanstiel, O., IV; Price, H. L.; Wang, L.; Juusola, J.; Kline, M.; Shah, S. M. The effect of polyamine homologation on the transport and cytotoxicity properties of polyamine-(DNA-intercalator) conjugates. J. Org. Chem. 2000, 65, 5590-5599.
19. Wang, L.; Price, H. L.; Juusola, J.; Kline, M.; Phanstiel, O., IV. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates. J. Med. Chem. 2001, 44, 3682-3691.
20. Delcros, J. G.; Tomasi, S.; Carrington, S.; Martin, B.; Renault, J.; Blagbrough, I. S.; Uriac, P. Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J. Med. Chem. 2002, 45, 5098-5111.
21. Fouace, S.; Gaudin, C.; Picard, S.; Corvaisier, S.; Renault, J.; Carboni, B.; Felden, B. Polyamine derivatives as selective RNaseA mimics. Nucleic Acids Res. 2004, 32, 151-157.
22. 1-spermine. Bioorg. Med. Chem. 1995, 3, 861-872.
23. Pérez-Florez, L.; Ruiz-Chica, A. J.; Delcros, J. G.; Sanchez-Jimenez, F.; Ramirez, F. J. Intercalation and groove binding of an acridine-spermine conjugate on DNA sequences: an FT-Raman and UV-visible absorption study. J. Mol. Struct. 2005, 744-747, 699-704.
24. Stark, P. A.; Thrall, B. D.; Meadows, G. G.; Abdel-Monem, M. M. Synthesis and evaluation of novel spermidine derivatives as targeted cancer chemotherapeutic agents. J. Med. Chem. 1992, 35, 4264-4269.
25. Verschoyle, R. D.; Carthew, P.; Holley, J. L.; Cullis, P.; Cohen, G. M. The comparative toxicity of chlorambucil and chlorambucil-spermidine conjugate to BALB/c mice. Cancer Lett. 1994, 85, 217-222.
26. Martin, B.; Posseme, F.; Le Barbier, C.; Carreaux, F.; Carboni, B.; Seiler, N.; Moulinoux, J. P.; Delcros, J. G. N-Benzylpolyamines as vectors of boron and fluorine for cancer therapy and imaging: synthesis and biological evaluation. J. Med. Chem. 2001, 44, 3653-3664.
27. Blagbrough, I. S.; Geall, A. J.; Neal, A. P. Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in nonviral gene therapy. Biochem. Soc. Trans. 2003, 31, 397-406.
28. Chen, K. Y.; Rinehart, C. A., Jr. Difference in putrescine transport in undifferentiated versus differentiated mouse NB-15 neuroblastoma cells. Biochem. Biophys. Res. Commun. 1981, 101, 243-249.
29. Wallace, H. M.; Keir, H. M. A comparison of polyamine metabolism in normal and transformed baby- hamster-kidney cells. Biochem. J. 1982, 202, 785-790.
30. Volkow, N.; Goldman, S. S.; Flamm, E. S.; Cravioto, H.; Wolf, A. P.; Brodie, J. D. Labeled putrescine as a probe in brain tumors. Science 1983, 221, 673-675.
31. Huber, M.; Pelletier, J. G.; Torossian, K.; Dionne, P.; Gamache, I.; Charestgaudreault, R.; Audette, M.; Poulin, R. 2,2′-Dithiobis(N-ethyl- spermine-5-carboxamide) is a high affinity, membrane-impermeant antagonist of the mammalian polyamine transport system. J. Biol Chem. 1996, 271, 27556-27563.
32. Covassin, L.; Desjardins, M.; Charest-Gaudreault, R.; Audette, M.; Bonneau, M. J.; Poulin, R. Synthesis of spermidine and norspermidine dimers as high affinity polyamine transport inhibitors. Bioorg. Med. Chem. Lett. 1999, 9, 1709-1714.
33. Weeks, R. S.; Vanderwerf, S. M.; Carlson, C. L.; Burns, M. R.; O'Day, C. L.; Cai, F.; Devens, B. H.; Webb, H. K. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO. Exp. Cell Res. 2000, 261, 293-302.
34. Burns, M. R.; Carlson, C. L.; Vanderwerf, S. M.; Ziemer, J. R.; Weeks, R. S.; Cai, F.; Webb, H. K.; Graminski, G. F. Amino acid/spermine conjugates: polyamine amides as potent spermidine uptake inhibitors. J. Med. Chem. 2001, 44, 3632-3644.
35. Covassin, L.; Desjardins, M.; Soulet, D.; Charest-Gaudreault, R.; Audette, M.; Poulin, R. Xylylated dimers of putrescine and polyamines: influence of the polyamine backbone on spermidine transport inhibition. Bioorg. Med. Chem. Lett. 2003, 13, 3267-3271.
36. Igarashi, K.; Kashiwagi, K. Polyamine transport in bacteria and yeast. Biochem. J. 1999, 344 Pt 3, 633-642.
37. Tomitori, H.; Kashiwagi, K.; Asakawa, T.; Kakinuma, Y.; Michael, A. J.; Igarashi, K. Multiple polyamine transport systems on the vacuolar membrane in yeast. Biochem. J. 2001, 353, 681-688.
38. Igarashi, K.; Ito, K.; Kashiwagi, K. Polyamine uptake systems in Escherichia coli. Res. Microbiol. 2001, 152, 271-278.
39. Hasne, M. P.; Ullman, B. Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major. J. Biol. Chem. 2005, 280, 15188-15194.
40. Belting, M.; Mani, K.; Jonsson, M.; Cheng, F.; Sandgren, S.; Jonsson, S.; Ding, K.; Delcros, J. G.; Fransson, L. A. Glypican-1 is a vehicle for polyamine uptake in mammalian cells: a pivital role for nitrosothiol-derived nitric oxide. J. Biol Chem. 2003, 278, 47181-47189.
41. Soulet, D.; Gagnon, B.; Rivest, S.; Audette, M.; Poulin, R. A fluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two-step mechanism. J. Biol. Chem. 2004.
42. Byers, T. L.; Bitonti, A. J.; McCann, P. P. Bis(benzyl)polyamine analogues are substrates for a mammalian cell-transport system which is distinct from the polyamine-transport system. Biochem. J. 1990, 269, 35-40.
43. Shao, D.; Xiao, L.; Ha, H. C.; Casero, R. A. Isolation of a polyamine transport deficient cell line from the human nonsmall cell lung carcinoma line NCI H157. J. Cell Physiol. 1996, 166, 43-48.
44. Seiler, N.; Douaud, F.; Renault, J.; Delcros, J. G.; Havouis, R.; Uriac, P.; Moulinoux, J. P. Polyamine sulfonamides with NMDA antagonist properties are potent calmodulin antagonists and cytotoxic agents. Int. J. Biochem. Cell Biol. 1998, 30, 393-406.
45. Delcros, J. G.; Vaultier, M.; Le Roch, N.; Havouis, R.; Moulinoux, J. P.; Seiler, N. Bis(7-amino-4-azaheptyl)dimethylsilane: A new tetramine with polyamine-like features. Effects on cell growth. Anti Cancer Drug Des. 1997, 12, 35-48.
46. Baek, K. J.; Das, T.; Gray, C. D.; Desai, S.; Hwang, K. C.; Gacchui, R.; Ludwig, M.; Im, M. J. A 50 kDa protein modulates guanine nucleotide binding of transglutaminase II. Biochemistry 1996, 35, 2651-2657.
47. Wang, C.; Delcros, J. G.; Biggerstaff, J.; Phanstiel, O., IV. Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine-anthracene conjugates. J. Med. Chem. 2003, 46, 2672-2682.
48. Wang, C.; Delcros, J. G.; Biggerstaff, J.; Phanstiel, O., IV. Synthesis and biological evaluation of N1-(anthracen-9-ylmethyl)triamines as molecular recognition elements for the polyamine transporter. J. Med. Chem. 2003, 46, 2663-2671.
49. 1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J. Med. Chem. 2004, 47, 6055-6069.
50. Heston, W. D.; Yang, C. R.; Pliner, L.; Russo, P.; Covey, D. F. Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line. Cancer Res. 1987, 47, 3627-3631.
51. 8-aziridinyl analogues of spermidine. Cancer Res. 1994, 54, 742-748.
52. Marton, L. J. Effects of treatment with DNA-directed cancer chemotherapeutic agents after polyamine depletion. Pharmacol. Ther. 1987, 32, 183-190.
53. Wang, C.; Delcros, J. G.; Cannon, L.; Konate, F.; Carias, H.; Biggerstaff, J.; Gardner, R. A.; Phanstiel, O., IV. Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J. Med. Chem. 2003, 46, 5129-5138.
54. Tomasi, S.; Eifler-Lima, V. L.; Le Roch, M.; Corbel, J. C.; Renault, J.; Uriac, P.; Mens, T.; Catros-Quemener, V.; Moulinoux, J. P. Depletion of polyamines potentiates the antitumour effect of tetracyclic amidines bearing a putrescine moiety. Pharm. Sci. 1997, 3, 241-247.
55. Eifler-Lima, V. L.; Uriac, P.; Huet, J.; Jenkins, T. C.; Thurston, D. E. Relationship between cytotoxicity and DNA-binding affinity of amidine derivatives of tetrahydroquino[4,3-b][1]benzazepines and tetrahydrobenzo[k] naphthyridines. Bioorg. Med. Chem. Lett. 1995, 5, 3003-3006.
56. Nisole, C.; Uriac, P.; Huet, J.; Toupet, L. Reactivity of 4-aminoazetidin-2-ones: obtention of gem-difunctional derivatives by N-1-C-4 cleavage. J. Chem. Res. 1991, 204-205.
57. Nisole, C.; Uriac, P.; Huet, J.; Toupet, L. Hété rocyclisation de sels d'iminium provenant de quelques β-amino-β- lactames et de leurs dérivés gem-difonctionnels. Tetrahedron 1992, 48, 1081-1098.
58. Bock, M. G.; DiPardo, R. M.; Evans, B. E.; Rittle, K. E.; Freidinger, R. M.; Chang, R. S.; Lotti, V. J. Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines. J. Med. Chem. 1988, 31, 264-268.
59. Foloppe, M. P.; Rault, S.; Robba, M. Pyrrolo[2,1-c][1,4]benzodiazepines: a mild conversion of thiolactam into amidine. Tetrahedron Lett. 1992, 33, 2803-2804.
60. Goodnow, R.; Konno, J. K.; Niwa, M.; Kallimopoulos, T.; Bukownik, R.; Lenares, D.; Nakanishi, K. Synthesis of glutamate receptor antagonist philanthotoxin-433 (PhTX-433) and its analogues. Tetrahedron 1990, 46, 3267-3286.
61. Seiler, N.; Knödgen, B. High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J. Chromatogr. 1980, 221, 227-235.
62. Morgan, A. R.; Lee, J. S.; Pulleyblank, D. E.; Murray, N. L.; Evans, D. H. Review: ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Res. 1979, 7, 547-569.
63. Stewart, K. D. The effect of structural changes in a polyamine backbone on its DNA-binding properties. Biochem. Biophys. Res. Commun. 1988, 152, 1441-1446.
64. Basu, H. S.; Schwietert, H. C.; Feuerstein, B. G.; Marton, L. J. Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes. Biochem. J. 1990, 269, 329-334.
65. Braunlin, W. H.; Strick, T. J.; Record, M. T., Jr. Equilibrium dialysis studies of polyamine binding to DNA. Biopolymers 1982, 21, 1301-1314.
66. Igarashi, K.; Sakamoto, I.; Goto, N.; Kashiwagi, K.; Homma, R.; Hirose, S. Interaction between polyamines and nucleic acids and phospholipids. Arch. Biochem. Biophys. 1982, 219, 438-443.
67. 8- acetylspermidine, and magnesium: determination from analysis of the broadening of thermal denaturation curves. Arch. Biochem. Biophys. 1986, 246, 225-232.
68. Edwards, M. L.; Snyder, R. D.; Stemerick, D. M. Synthesis and DNA-binding properties of polyamine analogues. J. Med. Chem. 1991, 34, 2414-2420.
69. Chin, D.; Means, A. R. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000, 10, 322-328.
70. Hait, W. N. Targeting calmodulin for the development of novel cancer chemotherapeutic agents. Anticancer Drug Des. 1987, 2, 139-149.
71. Walters, J. D.; Johnson, J. D. Inhibition of cyclic nucleotide phosphodiesterase and calcineurin by spermine, a calcium-independent calmodulin antagonist. Biochim. Biophys. Acta 1988, 957, 138-142.
72. Le Roch, N.; Douaud, F.; Havouis, R.; Delcros, J. G.; Vaultier, M.; Moulinoux, J. P.; Seiler, N. Dimethylsilane polyamines: cytostatic compounds with potentials as anticancer drugs. II. Uptake and potential cytotoxic mechanisms. Anticancer Res. 2002, 22, 3765-3776.
73. Seiler, N. Pharmacological aspects of cytotoxic polyamine analogues and derivatives for cancer therapy. Pharmacol. Ther. 2005, 107, 99-119.
74. Heston, W. D.; Charles, M. Calmodulin antagonist inhibition of polyamine transport in prostatic cancer cells in vitro. Biochem. Pharmacol. 1988, 37, 2511-2514.
75. Khan, N. A.; Sezan, A.; Quemener, V.; Moulinoux, J. P. Polyamine transport regulation by calcium and calmodulin: role of Ca(2+)-ATPase. J. Cell Physiol. 1993, 157, 493-501.
76. Scemama, J. L.; Grabie, V.; Seidel, E. R. Characterization of univectorial polyamine transport in duodenal crypt cell line. Am. J. Physiol. 1993, 265, G851-856.
77. Juranic, Z.; Joksimovic, J.; Spuzic, I.; Juranic, I.; Kidric, M. Amine oxidase-mediated cytotoxicity of spermine and epinephrine to human myelogenous leukemia K562 cells. Neoplasma 1992, 39, 273-277.
78. Averill-Bates, D. A.; Agostinelli, E.; Przybytkowski, E.; Mateescu, M. A.; Mondovi, B. Cytotoxicity and kinetic analysis of purified bovine serum amine oxidase in the presence of spermine in Chinese hamster ovary cells. Arch. Biochem. Biophys. 1993, 300, 75-79.
79. Bergeron, R. J.; McManis, J. S.; Liu, C. Z.; Feng, Y.; Weimar, W. R.; Luchetta, G. R.; Wu, Q.; Ortiz-Ocasio, J.; Vinson, J. R.; Kramer, D.; et al. Antiproliferative properties of polyamine analogues: a structure-activity study. J. Med. Chem. 1994, 37, 3464-3476.
80. Bergeron, R. J.; Feng, Y.; Weimar, W. R.; McManis, J. S.; Dimova, H.; Porter, C.; Raisler, B.; Phanstiel, O. A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J. Med. Chem. 1997, 40, 1475-1494.
81. Li, Y. L.; MacKerell, A. D.; Egorin, M. J.; Ballesteros, M. F.; Rosen, D. M.; Wu, Y. Y.; Blamble, D. A.; Callery, P. S. Comparative molecular field analysis-based predictive model of structure-function relationships of polyamine transport inhibitors in L1210 cells. Cancer Res. 1997, 57, 234-239.
82. Porter, C. W.; Miller, J.; Bergeron, R. J. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res. 1984, 44, 126-128.
83. Soulet, D.; Covassin, L.; Kaouass, M.; Charest-Gaudreault, R.; Audette, M.; Poulin, R. Role of endocytosis in the internalization of spermidine-C(2)-BODIPY, a highly fluorescent probe of polyamine transport. Biochem. J. 2002, 367, 347-357.
84. Cullis, P. M.; Green, R. E.; Merson-Davies, L.; Travis, N. Probing the mechanism of transport and compartimentalisation of polyamines in mammalian cells. Chem. Biol. 1999, 6, 717-729.
85. 8-bis(ethyl)spermidine, an apparent regulator of the enzyme. Cancer Res. 1986, 46, 6279-6285.
86. Byers, T. L.; Pegg, A. E. Properties and physiological function of the polyamine transport system. Am. J. Physiol. 1989, 257, C545-C553.
87. Byers, T. L.; Kameji, R.; Rannels, D. E.; Pegg, A. E. Multiple pathways for uptake of paraquat, methylglyoxal bis(guanylhydra-zone), and polyamines. Am. J. Physiol. 1987, 252, C663-669.
88. Minchin, R. F.; Raso, A.; Martin, R. L.; Ilett, K. F. Evidence for the existence of distinct transporters for the polyamines putrescine and spermidine in B16 melanoma cells. Eur. J. Biochem. 1991, 200, 457-462.
89. Martin, B.; Posseme, F.; Le Barbier, C.; Carreaux, F.; Carboni, B.; Seiler, N.; Moulinoux, J. P.; Delcros, J. G. (Z)-1,4-diamino-2-butene as a vector of boron, fluorine, or iodine for cancer therapy and imaging: synthesis and biological evaluation. Bioorg. Med. Chem. 2002, 10, 2863-2871.
90. Graminski, G. F.; Carlson, C. L.; Ziemer, J. R.; Cai, F.; Vermeulen, N. M.; Vanderwerf, S. M.; Burns, M. R. Synthesis of bis-spermine dimers that are potent polyamine transport inhibitors. Bioorg. Med. Chem. Lett. 2002, 12, 35-40.
91. Mitchell, J. L.; Judd, G. G.; Bareyal-Leyser, A.; Ling, S. Y. Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. Biochem. J. 1994, 299, 19-22.
92. Sakata, K.; Fukuchi-Shimogori, T.; Kashiwagi, K.; Igarashi, K. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport. Biochem. Biophys. Res. Commun. 1997, 238, 415-419.
93. Snyder, S. H.; Hendley, E. D. A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase. J. Pharmacol. Exp. Ther. 1968, 163, 386-392.
94. Carmichael, J.; Degraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 1987, 47, 943-946.
95. Clement, S.; Delcros, J. G.; Feuerstein, B. G. Spermine uptake is necessary to induce haemoglobin synthesis in murine erythroleukaemia cells. Biochem. J. 1995, 312, 933-938.
96. Cheng, Y.; Prusoff, W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
97. Torossian, K.; Audette, M.; Poulin, R. Substrate protection against inactivation of the mammalian polyamine-transport system by 1-ethyl-3-(3- dimethylaminopropyl)carbodiimide. Biochem. J. 1996, 319, 21-26.
98. Lowry, O. H.; Rosenbrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.